Similar serovar and drug susceptibility profiles among AIDS-related Mycobacterium avium isolates from diverse geographic locations

Am J Med Sci. 1997 Jun;313(6):352-4. doi: 10.1097/00000441-199706000-00007.

Abstract

Serotyping was performed on Mycobacterium avium isolates from 40 AIDS patients from 5 geographic sites: Boston (17 patients), New Hampshire (4 patients), Finland (12 patients), Trinidad (3 patients), and Kenya (4 patients). Serovars were similar from the five sites. Serovars 4 and 8 were the most common. In addition, minimal inhibitory concentrations to 8 antimicrobial agents were determined for 31 of these isolates and for 21 additional patient isolates from these sites. Minimal inhibitory concentration90 values for clarithromycin, azithromycin, clofazimine, amikacin, ethambutol, ciprofloxacin, sparfloxacin, and rifabutin were similar for isolates from the five geographic sites. Antimicrobial susceptibility patterns did not differ by serovar.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS-Related Opportunistic Infections / blood
  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / microbiology*
  • Anti-Bacterial Agents / pharmacology
  • CD4 Lymphocyte Count
  • Feces / microbiology
  • Geography
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium avium Complex / classification*
  • Mycobacterium avium Complex / drug effects
  • Mycobacterium avium Complex / isolation & purification
  • Mycobacterium avium-intracellulare Infection / drug therapy
  • Mycobacterium avium-intracellulare Infection / microbiology*
  • Serotyping
  • Sputum / microbiology

Substances

  • Anti-Bacterial Agents